#LCSM Transcript
Healthcare social media transcript of the #LCSM hashtag.
– ().
See #LCSM Influencers/Analytics.
Profile | Tweet |
---|---|
NCI Cancer Stats @NCICancerStats Check out our map story on #LungCancer incidence, mortality, and smoking rates at the state and country level: https://t.co/wDxSFyFxAa #LCSM https://t.co/pPia4kP6vZ | |
Brendon Stiles @BrendonStilesMD Hi #lcsm | |
Faces of Lung Cancer @LungCancerFaces @BrendonStilesMD Hey Brendon! #lcsm | |
Brendon Stiles @BrendonStilesMD Looking forward to a great chat about lung cancer at #ASCO18 #lcsm | |
Janet Freeman-Daily @JFreemanDaily Welcome to #LCSM Chat! Tonight’s topic is “Lung Cancer at ASCO 2018.” A brief overview is available here: https://t.co/QZHYZdw6aq | |
Janet Freeman-Daily @JFreemanDaily Brendon! Glad you're able to join us. I'll need help explaining some of these abstracts! @BrendonStilesMD #lcsm | |
#LCSM Chat @lcsmchat RT @JFreemanDaily: Welcome to #LCSM Chat! Tonight’s topic is “Lung Cancer at ASCO 2018.” A brief overview is available here: Welcome to #LCSM Chat! Tonight’s topic is “Lung Cancer at ASCO 2018.” A brief overview is available here: https://t.co/QZHYZdw6aq | |
Faces of Lung Cancer @LungCancerFaces RT @JFreemanDaily: Welcome to #LCSM Chat! Tonight’s topic is “Lung Cancer at ASCO 2018.” A brief overview is available here: Welcome to #LCSM Chat! Tonight’s topic is “Lung Cancer at ASCO 2018.” A brief overview is available here: https://t.co/QZHYZdw6aq | |
Brendon Stiles @BrendonStilesMD @JFreemanDaily I will give it my best shot! At least for the early stage! #lcsm | |
Faces of Lung Cancer @LungCancerFaces Deana Hendrickson in Los Angeles here. Look forward to chatting about #ASCO18 lung cancer. #lcsm | |
Karen Loss @cancertrek Hi everyone. Karen here. #lcsm | |
Janet Freeman-Daily @JFreemanDaily If' you're listening, please tweet #LCSM so we'll know who'se in the audience | |
Brendon Stiles @BrendonStilesMD I think #LungCancer will be hot again at #ASCO18 #lcsm | |
Faces of Lung Cancer @LungCancerFaces @cancertrek Hi Karen! How are you? #lcsm | |
Janet Freeman-Daily @JFreemanDaily @cancertrek Hey Karen! #lcsm | |
Janet Freeman-Daily @JFreemanDaily @BrendonStilesMD Indeed -- several hot abstracts on @JackWestMD's lists this year. #lcsm | |
Anita Figueras @scifiknitter RT @JFreemanDaily: Welcome to #LCSM Chat! Tonight’s topic is “Lung Cancer at ASCO 2018.” A brief overview is available here: Welcome to #LCSM Chat! Tonight’s topic is “Lung Cancer at ASCO 2018.” A brief overview is available here: https://t.co/QZHYZdw6aq | |
#LCSM Chat @lcsmchat RT @JFreemanDaily: If' you're listening, please tweet #LCSM so we'll know who'se in the audience | |
Faces of Lung Cancer @LungCancerFaces RT @JFreemanDaily: If' you're listening, please tweet #LCSM so we'll know who'se in the audience | |
Anita Figueras @scifiknitter Anita here! #LCSM | |
Faces of Lung Cancer @LungCancerFaces @scifiknitter Hi Anita! #lcsm | |
Janet Freeman-Daily @JFreemanDaily We'll get started in a few minutes -- please take a moment to introduce yourselves #lcsm | |
Brendon Stiles @BrendonStilesMD @scifiknitter Hi Anita! #lcsm | |
Janet Freeman-Daily @JFreemanDaily I’m your moderator Janet Freeman-Daily: writer (https://t.co/OBCc88h7Jg), science geek, stage IV #lungcancer patient/activist #lcsm | |
Janet Freeman-Daily @JFreemanDaily If you are new to Twitter chats and/or #LCSM Chat, you might find our primer on how to participate helpful https://t.co/5g28sSzfTD | |
Geri Massa @GeriGerim13 Good Evening All Can someone send me the link to be able chat, I don’t know the name of it .. you can watch and seethe chat rather than refreshing for new posts If I make any sense, lol #LCSM | |
Anita Figueras @scifiknitter @LungCancerFaces Hi Deana! #lcsm | |
Janet Freeman-Daily @JFreemanDaily This chat will be a different format than usual--we'll be posting & discussing abstracts from the upcoming #ASCO18 annual meeting #lcsm | |
Brendon Stiles @BrendonStilesMD Brendon Stiles here...thoracic surgeon, researcher, seeking clarity from abstracts, which is always a challenge! #lcsm | |
Anita Figueras @scifiknitter @BrendonStilesMD Hi Brendon! Thanks for helping us understand these abstracts. #lcsm | |
#LCSM Chat @lcsmchat @GeriGerim13 Hi Geri! Try https://t.co/REUOM3GZHV #lcsm | |
Janet Freeman-Daily @JFreemanDaily I know @scifiknitter, @cancertrek, @BrendonStilesMD and @lungcancerfaces all know what @ASCO is-- anyone need an overview? #lcsm | |
#LCSM Chat @lcsmchat RT @JFreemanDaily: This chat will be a different format than usual--we'll be posting & discussing abstracts from the upcoming #ASCO18 annual meeting #lcsm | |
LungCancer.net @LungCancer_HU Hi! Margot here #lcsm | |
Lecia Sequist, MD, MPH @LeciaSequist Hey #LCSM, welcome rad Onc doc extraordinaire @HenningWillers to twitter!! | |
#LCSM Chat @lcsmchat RT @JFreemanDaily: I know @scifiknitter, @cancertrek, @BrendonStilesMD and @lungcancerfaces all know what @ASCO is-- anyone need an overview? #lcsm | |
Faces of Lung Cancer @LungCancerFaces @LeciaSequist @HenningWillers Welcome! #lcsm | |
Karen Loss @cancertrek @LungCancer_HU Hi Margot! #lcsm | |
Brendon Stiles @BrendonStilesMD @LeciaSequist @HenningWillers Thanks to both of you for joining! #lcsm | |
Faces of Lung Cancer @LungCancerFaces @LungCancer_HU Hey Margot! #lcsm | |
LungCancer.net @LungCancer_HU @cancertrek hi! #lcsm | |
#LCSM Chat @lcsmchat RT @LeciaSequist: Hey #LCSM, welcome rad Onc doc extraordinaire @HenningWillers to twitter!! | |
Anita Figueras @scifiknitter @LungCancer_HU Hey Margot! #lcsm | |
LungCancer.net @LungCancer_HU @LungCancerFaces hey!! #lcsm | |
LungCancer.net @LungCancer_HU @scifiknitter hi Anita! #lcsm | |
Janet Freeman-Daily @JFreemanDaily Let's get started! @BrendonStilesMD , do you have any abstracts you'd like to discuss? #LCSM | |
KC Dill @kasedill Hello from Texas how is everyone? #lcsm | |
OncLive.com @OncLive Adding atezolizumab to nab-paclitaxel and carboplatin in the frontline setting significantly improved OS in patients with advanced NSCLC, according to findings from the phase III IMpower130 study #lcsm https://t.co/GzhSEs26ld | |
Faces of Lung Cancer @LungCancerFaces @kasedill Howdy! Thanks for joining. #lcsm | |
Anita Figueras @scifiknitter @LeciaSequist @HenningWillers Hello @LeciaSequist & @HenningWillers. Looking forward to your insights. #lcsm | |
Brendon Stiles @BrendonStilesMD Well...I like the concept of 8502 regarding the importance of lymph node dissection in earlier stage. Not sure I believe the "kit" makes the difference, but we not surgical quality matters. #lcsm | |
#LCSM Chat @lcsmchat RT @JFreemanDaily: Let's get started! @BrendonStilesMD , do you have any abstracts you'd like to discuss? #LCSM | |
#LCSM Chat @lcsmchat RT @BrendonStilesMD: Well...I like the concept of 8502 regarding the importance of lymph node dissection in earlier stage. Not sure I believe the "kit" makes the difference, but we not surgical quality matters. #lcsm | |
Brendon Stiles @BrendonStilesMD And of course, since @henningWillers is here, I am happy to talk about 8511 showing inferiority of SBRT to surgery for matched early stage patients (with caveats) and the update of 8512 showing high SBRT failure rates! Sorry - couldn't help it. #lcsm | |
Janet Freeman-Daily @JFreemanDaily @BrendonStilesMD Please translate: what does "lymph node dissection" mean? #LCSM | |
Karen Loss @cancertrek @JFreemanDaily @BrendonStilesMD Paging Dr. Stiles. ;) #lcsm | |
Friends of Ernie @ErniesLibrary #adcsm #ancsm #bcsm #blcsm #btsm #crcsm #esophca #gynca #hpbcsm #hncsm #krcc #lcsm #lylsm #melnm #pancsm #pcsm #srcma #stomca #testca #thymca https://t.co/LowKv2yy8w | |
#LCSM Chat @lcsmchat @BrendonStilesMD Brendon, can you break your tweet above into two tweets. Doesn't show up in tchat because it's over 140. #lcsm | |
Brendon Stiles @BrendonStilesMD 8512 is important. Shows long term treatment failure, either loco regional or metastatic recurrence in 27/65 stage IA patients after SBRT - although dose slightly lower than that used now. #lcsm | |
#LCSM Chat @lcsmchat RT @BrendonStilesMD: And of course, since @henningWillers is here, I am happy to talk about 8511 showing inferiority of SBRT to surgery for matched early stage patients (with caveats) and the update of 8512 showing high SBRT failure rates! Sorry - couldn't help it. #lcsm | |
#LCSM Chat @lcsmchat RT @JFreemanDaily: @BrendonStilesMD Please translate: @BrendonStilesMD Please translate: what does "lymph node dissection" mean? #LCSM | |
Stephen Ramey @StephenRameyMD RT @natlestercoll: @NRGonc 0618 shows 96% local control at 4 years for operable T1-T2 peripheral NSCLC treated with SBRT #radonc #lcsm https://t.co/nsxMJ9CY6A @JAMAOnc | |
#LCSM Chat @lcsmchat RT @BrendonStilesMD: 8512 is important. Shows long term treatment failure, either loco regional or metastatic recurrence in 27/65 stage IA patients after SBRT - although dose slightly lower than that used now. #lcsm | |
Brendon Stiles @BrendonStilesMD Lymph node dissection - important for surgeons to remove nodes. #lcsm | |
Brendon Stiles @BrendonStilesMD Node removal is important for accurate staging and is quality indicator. #lcsm | |
Karen Loss @cancertrek RT @BrendonStilesMD: Node removal is important for accurate staging and is quality indicator. #lcsm | |
#LCSM Chat @lcsmchat RT @BrendonStilesMD: Lymph node dissection - important for surgeons to remove nodes. #lcsm | |
#LCSM Chat @lcsmchat RT @BrendonStilesMD: Node removal is important for accurate staging and is quality indicator. #lcsm | |
Brendon Stiles @BrendonStilesMD This is from 8502 using a kit to improve node counting. #lcsm | |
Janet Freeman-Daily @JFreemanDaily @BrendonStilesMD Since most of the people in this chat are patients rather than surgeons, can you tell us the findings of the abstract? #lcsm | |
Brendon Stiles @BrendonStilesMD 8511 is surgery vs. SBRT for early cancer. #lcsm | |
Faces of Lung Cancer @LungCancerFaces @DrRiyazShah Welcome! You'll be fine. Promise. @lindacoate @n8pennell #lcsm | |
#LCSM Chat @lcsmchat RT @BrendonStilesMD: This is from 8502 using a kit to improve node counting. #lcsm | |
#LCSM Chat @lcsmchat RT @JFreemanDaily: @BrendonStilesMD Since most of the people in this chat are patients rather than surgeons, can you tell us the findings of the abstract? #lcsm | |
#LCSM Chat @lcsmchat RT @BrendonStilesMD: 8511 is surgery vs. SBRT for early cancer. #lcsm | |
Brendon Stiles @BrendonStilesMD @LeciaSequist - what do you think of ARCHER 1050? Where do we use newer EGFR TKIs? #lcsm | |
Faces of Lung Cancer @LungCancerFaces RT @BrendonStilesMD: @LeciaSequist - what do you think of ARCHER 1050? Where do we use newer EGFR TKIs? #lcsm | |
#LCSM Chat @lcsmchat RT @BrendonStilesMD: @LeciaSequist - what do you think of ARCHER 1050? Where do we use newer EGFR TKIs? #lcsm | |
Brendon Stiles @BrendonStilesMD @HenningWillers What do you make of the JCOG study, abstract 8512, showing long term results with SBRT? #lcsm | |
#LCSM Chat @lcsmchat RT @BrendonStilesMD: @HenningWillers What do you make of the JCOG study, abstract 8512, showing long term results with SBRT? #lcsm | |
Brendon Stiles @BrendonStilesMD Also like Jack point out 8501. Blood tests will continue to advance into clinical care. #lcsm | |
Janet Freeman-Daily @JFreemanDaily FYI, here is @jackwestmd's list of Top 5 #ASCO19 abstracts for #lungcancer #LCSM https://t.co/aBY8RJKm37 https://t.co/MVxeGzP3ow | |
Geri Massa @GeriGerim13 #lcsm I am assuming the numbers mentioned are different genetic cell identifiers ? Topic I’m not familiar with Thanks 😀 | |
#LCSM Chat @lcsmchat RT @BrendonStilesMD: Also like Jack point out 8501. Blood tests will continue to advance into clinical care. #lcsm | |
#LCSM Chat @lcsmchat RT @JFreemanDaily: FYI, here is @jackwestmd's list of Top 5 #ASCO19 abstracts for #lungcancer #LCSM https://t.co/aBY8RJKm37 https://t.co/MVxeGzP3ow | |
Brendon Stiles @BrendonStilesMD @JFreemanDaily Basically - shows importance of quality control in surgery. #lcsm | |
Brendon Stiles @BrendonStilesMD Lots of combo-immunotherapy trials, based on concept that chemo-IO may complement each other. #lcsm | |
Henning Willers, MD @HenningWillers @BrendonStilesMD @BrendonStilesMD Good to be here! Long awaited data, showing promise. However I do not buy (quite yet) into the notion that SBRT can compete with anatomical resection in operable patient #lcsm | |
Faces of Lung Cancer @LungCancerFaces @GeriGerim13 The numbers on Jack's list are assigned by ASCO. They have no meaning beyond being identifiers for each abstract. #lcsm | |
#LCSM Chat @lcsmchat RT @BrendonStilesMD: @JFreemanDaily Basically - shows importance of quality control in surgery. #lcsm | |
Geri Massa @GeriGerim13 Names of trials ? #LCSM | |
Montessa M. Lee @MontessaLee RT @ivybelkins: Heading to #ASCO18 soon! @jillfeldman4 and I will be representing the @EGFRResisters and we look forward to checking out some of these abstracts! #lcsm https://t.co/hg5OkZUH6p | |
Montessa M. Lee @MontessaLee RT @jillfeldman4: On our way to #ASCO18. Looking forward to @EGFRResisters inaugural Think Tank with @jfowlerpharmd. @ivybelkins and I will be tweeting from the conference #LCSM | |
Brendon Stiles @BrendonStilesMD @HenningWillers Totally fair and I appreciate the "quite yet"! Good to see you here on twitter. #lcsm | |
#LCSM Chat @lcsmchat RT @BrendonStilesMD: Lots of combo-immunotherapy trials, based on concept that chemo-IO may complement each other. #lcsm | |
#LCSM Chat @lcsmchat RT @HenningWillers: @BrendonStilesMD @BrendonStilesMD Good to be here! Long awaited data, showing promise. However I do not buy (quite yet) into the notion that SBRT can compete with anatomical resection in operable patient #lcsm | |
Brendon Stiles @BrendonStilesMD @HenningWillers One more #RadOnc for me to learn from! #lcsm | |
Henning Willers, MD @HenningWillers @BrendonStilesMD Generally, distant failure rates in stage I patients treated with surgery or SBRT are comparable (15-20%) #lcsm | |
Brendon Stiles @BrendonStilesMD @GeriGerim13 KEYNOTE 024 and 407, IMPOWER 131, CHECKMATE 227 #lcsm | |
Lecia Sequist, MD, MPH @LeciaSequist Need to see full data Monday from @TonyMok9 but IMO it is unlikely that daco can replace osi as top choice 1st line. Tox is signif worse, PFS is shorter in a study cohort w more favorable prognosis (no CNS mets). But 1st Egfr study w an OS benefit is an historic landmark! https://t.co/feH8PhmZUc | |
Janet Freeman-Daily @JFreemanDaily @GeriGerim13 Geri--some clinical trials have memorable names, but that's independent of the abstract number assigned by @ASCO for a meeting. #LCSM | |
#LCSM Chat @lcsmchat Hi @peggyddennis! Glad to see you. #lcsm | |
Brendon Stiles @BrendonStilesMD @GeriGerim13 Keep your eye out for news updates about these. May extend groups of patients who benefit from IO. #lcsm | |
Janet Freeman-Daily @JFreemanDaily @HenningWillers @BrendonStilesMD Hi Henning--glad you dropped in to #LCSM Chat! | |
#LCSM Chat @lcsmchat RT @BrendonStilesMD: @GeriGerim13 KEYNOTE 024 and 407, IMPOWER 131, CHECKMATE 227 #lcsm | |
#LCSM Chat @lcsmchat RT @BrendonStilesMD: @GeriGerim13 Keep your eye out for news updates about these. May extend groups of patients who benefit from IO. #lcsm | |
#LCSM Chat @lcsmchat RT @trnsltnl: | |
Brendon Stiles @BrendonStilesMD @LeciaSequist @TonyMok9 Well said. Important study for sure and more hope for #EGFR patients. #lcsm | |
Janet Freeman-Daily @JFreemanDaily I'll be very interested to see IMPOWER150 results to see if chemo+immunotherapy might be helpful for NSCLC with genomic drivers. #LCSM | |
Faces of Lung Cancer @LungCancerFaces Chatters, please note that although twitter allows for 280 characters, most tweet chat tools only allow for 140, so keep it short, pls #lcsm | |
#LCSM Chat @lcsmchat #lcsm https://t.co/irhiTJxXxd | |
#LCSM Chat @lcsmchat RT @JFreemanDaily: I'll be very interested to see IMPOWER150 results to see if chemo+immunotherapy might be helpful for NSCLC with genomic drivers. #LCSM | |
Henning Willers, MD @HenningWillers @BrendonStilesMD Good study!! Not clear to me how many patients had lobectomy. Again I do not think that SBRT can compete with lobectomy, but other long-term data show that local failure after SBRT is comparable to wedge and thus SBRT good option for elderly high risk population. #lcsm | |
#LCSM Chat @lcsmchat RT @LungCancerFaces: Chatters, please note that although twitter allows for 280 characters, most tweet chat tools only allow for 140, so keep it short, pls #lcsm | |
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD RT @BrendonStilesMD: @GeriGerim13 Keep your eye out for news updates about these. May extend groups of patients who benefit from IO. #lcsm | |
Brendon Stiles @BrendonStilesMD @LungCancerFaces OK #lcsm | |
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD RT @JFreemanDaily: FYI, here is @jackwestmd's list of Top 5 #ASCO19 abstracts for #lungcancer #LCSM https://t.co/aBY8RJKm37 https://t.co/MVxeGzP3ow | |
Brendon Stiles @BrendonStilesMD Get it? @LungCancerFaces #lcsm | |
Janet Freeman-Daily @JFreemanDaily @LeciaSequist @TonyMok9 Lecia! So glad to see you on #LCSM Chat. Please remember to include #LCSM in your tweets so your post will show up in the feed. | |
#LCSM Chat @lcsmchat RT @HenningWillers: @BrendonStilesMD Good study!! Not clear to me how many patients had lobectomy. Again I do not think that SBRT can compete with lobectomy, but other long-term data show that local failure after SBRT is comparable to wedge and thus SBRT good option for elderly high risk population. #lcsm | |
Brendon Stiles @BrendonStilesMD @HenningWillers Maybe...I still quibble with definition of "long term" in SBRT literature. #lcsm | |
#LCSM Chat @lcsmchat RT @JFreemanDaily: @LeciaSequist @TonyMok9 Lecia! So glad to see you on #LCSM Chat. Please remember to include #LCSM in your tweets so your post will show up in the feed. | |
Janet Freeman-Daily @JFreemanDaily @BrendonStilesMD @LungCancerFaces Yes, I see you! :) #LCSM | |
#LCSM Chat @lcsmchat Thanks for joining! #lcsm https://t.co/zeAqVraV0F | |
Brendon Stiles @BrendonStilesMD Will be nice to see if IO + chemo works for patients w/ PDL1<1% in CHECKMATE 227 #lcsm | |
#LCSM Chat @lcsmchat RT @BrendonStilesMD: @HenningWillers Maybe...I still quibble with definition of "long term" in SBRT literature. #lcsm | |
#LCSM Chat @lcsmchat RT @BrendonStilesMD: Will be nice to see if IO + chemo works for patients w/ PDL1<1% in CHECKMATE 227 #lcsm | |
KC Dill @kasedill If your tumor wan not genetically tested and you had a complete response to IO how does a person determine if there is a mutation present? A little off topic but I am curious. #lcsm | |
Brendon Stiles @BrendonStilesMD Here is ARCHER1050 news release https://t.co/uPNQgRvMTd #lcsm | |
#LCSM Chat @lcsmchat RT @kasedill: If your tumor wan not genetically tested and you had a complete response to IO how does a person determine if there is a mutation present? A little off topic but I am curious. #lcsm | |
Janet Freeman-Daily @JFreemanDaily #ASCO18 will cover a lot of topics of interest to #lungcancer besides drugs, surgery, and radiation. Patient care, and "value" will also be big. #LCSM | |
Anita Figueras @scifiknitter @BrendonStilesMD Is this a case where we patients should be even more concerned with OS than PFS? #LCSM | |
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD RT @BrendonStilesMD: Here is ARCHER1050 news release https://t.co/uPNQgRvMTd #lcsm | |
#LCSM Chat @lcsmchat RT @BrendonStilesMD: Here is ARCHER1050 news release https://t.co/uPNQgRvMTd #lcsm | |
#LCSM Chat @lcsmchat RT @JFreemanDaily: #ASCO18 will cover a lot of topics of interest to #lungcancer besides drugs, surgery, and radiation. Patient care, and "value" will also be big. #LCSM | |
#LCSM Chat @lcsmchat RT @scifiknitter: @BrendonStilesMD Is this a case where we patients should be even more concerned with OS than PFS? #LCSM | |
Henning Willers, MD @HenningWillers @BrendonStilesMD 5-year local failure rates after SBRT in 3 prospective trials (RTOG x 2 and MDACC) are 7-8%, which is not bad! Criticism from surgeons has been that some local failures may still hide behind radiation fibrosis. Time will tell. #lcsm | |
Friends of Ernie @ErniesLibrary #adcsm #ancsm #bcsm #blcsm #btsm #crcsm #esophca #gynca #hpbcsm #hncsm #krcc #lcsm #lylsm #melnm #pancsm #pcsm #srcma #stomca #testca #thymca https://t.co/qwBFV2icAa https://t.co/JNM9FRidQr | |
Brendon Stiles @BrendonStilesMD Here is @jackwest list https://t.co/rk5lsKSDU4 #lcsm | |
#LCSM Chat @lcsmchat Welcome, Michelle. #LCSM https://t.co/5Fl4ORodcC | |
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD RT @JFreemanDaily: #ASCO18 will cover a lot of topics of interest to #lungcancer besides drugs, surgery, and radiation. Patient care, and "value" will also be big. #LCSM | |
#LCSM Chat @lcsmchat RT @HenningWillers: @BrendonStilesMD 5-year local failure rates after SBRT in 3 prospective trials (RTOG x 2 and MDACC) are 7-8%, which is not bad! Criticism from surgeons has been that some local failures may still hide behind radiation fibrosis. Time will tell. #lcsm | |
#LCSM Chat @lcsmchat RT @BrendonStilesMD: Here is @jackwest list https://t.co/rk5lsKSDU4 #lcsm | |
Brendon Stiles @BrendonStilesMD @scifiknitter We should always be more concerned with OS than PFS!!! Although there is value in PFS #lcsm | |
Janet Freeman-Daily @JFreemanDaily @kasedill If you had a complete response to immunotherapy, does it matter if your cancer has a driving mutation? You can test it later **IF** your cancer returns. #LCSM | |
#LCSM Chat @lcsmchat RT @BrendonStilesMD: @scifiknitter We should always be more concerned with OS than PFS!!! Although there is value in PFS #lcsm | |
#LCSM Chat @lcsmchat RT @JFreemanDaily: @kasedill If you had a complete response to immunotherapy, does it matter if your cancer has a driving mutation? You can test it later **IF** your cancer returns. #LCSM | |
Anita Figueras @scifiknitter RT @BrendonStilesMD: @scifiknitter We should always be more concerned with OS than PFS!!! Although there is value in PFS #lcsm | |
Janet Freeman-Daily @JFreemanDaily Nice that this #LCSM Chat is slower than usual. If you think following a fast-pace tweetchat is tough, ASCO is like being run over on a speedway. | |
#LCSM Chat @lcsmchat RT @trnsltnl: | |
#LCSM Chat @lcsmchat RT @JFreemanDaily: Nice that this #LCSM Chat is slower than usual. If you think following a fast-pace tweetchat is tough, ASCO is like being run over on a speedway. | |
Janet Freeman-Daily @JFreemanDaily @BrendonStilesMD @jackwest Thank you, @BrendonStilesMD. My PC and I are having a disagreement about whether I should be able to see #LCSM Chat's tweet. | |
Brendon Stiles @BrendonStilesMD Here is 8512. Would have made plenary session at surgical meeting! https://t.co/6DlljTUhsf #lcsm | |
Faces of Lung Cancer @LungCancerFaces I see you Steve! @dark_hawk_98 #lcsm | |
#LCSM Chat @lcsmchat RT @JFreemanDaily: @BrendonStilesMD @jackwest Thank you, @BrendonStilesMD. My PC and I are having a disagreement about whether I should be able to see #LCSM Chat's tweet. | |
Anita Figueras @scifiknitter @JFreemanDaily An example: @n8pennell's analysis that NGS testing at diagnosis would save money overall. #LCSM | |
#LCSM Chat @lcsmchat RT @BrendonStilesMD: Here is 8512. Would have made plenary session at surgical meeting! https://t.co/6DlljTUhsf #lcsm | |
#LCSM Chat @lcsmchat RT @scifiknitter: @JFreemanDaily An example: @JFreemanDaily An example: @n8pennell's analysis that NGS testing at diagnosis would save money overall. #LCSM | |
Henning Willers, MD @HenningWillers @BrendonStilesMD It does make it difficult to compare pT1/2 N0 population (which has the cN0pN1/2 patients removed) to clinicaly staged SBRT cohorts. Generally, nodal failure rates after SBRT are lower than one would expect from surgical literature (<10%) #lcsm | |
Janet Freeman-Daily @JFreemanDaily Hey @TimAllenMDJD , any cool #ASCO18 abstracts about pathology? #LCSM | |
#LCSM Chat @lcsmchat RT @HenningWillers: @BrendonStilesMD It does make it difficult to compare pT1/2 N0 population (which has the cN0pN1/2 patients removed) to clinicaly staged SBRT cohorts. Generally, nodal failure rates after SBRT are lower than one would expect from surgical literature (<10%) #lcsm | |
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD RT @JFreemanDaily: @kasedill If you had a complete response to immunotherapy, does it matter if your cancer has a driving mutation? You can test it later **IF** your cancer returns. #LCSM | |
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD RT @BrendonStilesMD: Here is @jackwest list https://t.co/rk5lsKSDU4 #lcsm | |
Brendon Stiles @BrendonStilesMD Here is the one about lymph nodes. https://t.co/4i872uuWq7 #lcsm | |
Janet Freeman-Daily @JFreemanDaily @scifiknitter @n8pennell Yes! Thanks for pointing that out, Anita. #lcsm | |
#LCSM Chat @lcsmchat RT @JFreemanDaily: Hey @TimAllenMDJD , any cool #ASCO18 abstracts about pathology? #LCSM | |
#LCSM Chat @lcsmchat RT @BrendonStilesMD: Here is the one about lymph nodes. https://t.co/4i872uuWq7 #lcsm | |
Michelle Burrus @saiwoman2 #LCSM | |
Brendon Stiles @BrendonStilesMD @HenningWillers Very true. This again demonstrates critical importance of nodal staging. #lcsm | |
Laura Greco @lgreco_ny Laura here late. Asco here I come! #lcsm | |
Brendon Stiles @BrendonStilesMD @HenningWillers Got to pick right patients and EBUS those with any possible N1/N2. #lcsm | |
Janet Freeman-Daily @JFreemanDaily RT @BrendonStilesMD: Here is 8512. Would have made plenary session at surgical meeting! https://t.co/6DlljTUhsf #lcsm | |
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD Thanks for asking, @JFreemanDaily I'm sure there are! Unfortunately I will not be able to attend this one... #Boston #lcsm https://t.co/JRd2IkuitX | |
Laura Greco @lgreco_ny RT @JFreemanDaily: I'll be very interested to see IMPOWER150 results to see if chemo+immunotherapy might be helpful for NSCLC with genomic drivers. #LCSM | |
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD RT @BrendonStilesMD: Here is the one about lymph nodes. https://t.co/4i872uuWq7 #lcsm | |
Faces of Lung Cancer @LungCancerFaces @saiwoman2 Welcome! #lcsm | |
Faces of Lung Cancer @LungCancerFaces @lgreco_ny Hey! Better late than never. #LCSM | |
#LCSM Chat @lcsmchat RT @BrendonStilesMD: @HenningWillers Very true. This again demonstrates critical importance of nodal staging. #lcsm | |
#LCSM Chat @lcsmchat RT @BrendonStilesMD: @HenningWillers Got to pick right patients and EBUS those with any possible N1/N2. #lcsm | |
#LCSM Chat @lcsmchat RT @TimAllenMDJD: Thanks for asking, @JFreemanDaily I'm sure there are! Unfortunately I will not be able to attend this one... #Boston #lcsm https://t.co/JRd2IkuitX | |
Brendon Stiles @BrendonStilesMD Ask @TimAllenMDJD how important this is! #lcsm | |
Janet Freeman-Daily @JFreemanDaily @lgreco_ny Hey Laura! Have you built your #ASCO18 schedule yet? #LCSM | |
Laura Greco @lgreco_ny RT @JFreemanDaily: @lgreco_ny Hey Laura! Have you built your #ASCO18 schedule yet? #LCSM | |
#LCSM Chat @lcsmchat RT @BrendonStilesMD: Ask @TimAllenMDJD how important this is! #lcsm | |
Laura Greco @lgreco_ny @JFreemanDaily I did last week, although I'm sure I'll change it. #lcsm | |
Janet Freeman-Daily @JFreemanDaily @TimAllenMDJD When will you be in #BOSTON? I'll be there starting 6/9-10. #LCSM | |
Brendon Stiles @BrendonStilesMD I am missing #ASCO18. Will follow on #SoMe. Too tired from Ljubljana! #lcsm | |
Tips for Diabetes @diabetic_li RT @DrSadhanaJ: And even second hand #smoking can cause toxic long term effects to #children. Let’s encourage a #healthyliving and #pollution free world! #WorldNoTobaccoDay #SmokeFreeWorld #smokefree #NoTobacco #LCSM #Cancer @NCIResearchCtr @CDCgov https://t.co/ld4FyuJa9P https://t.co/K8xNwR7iMQ | |
Tessa Sheldon @tessa_perrin Swinging by.... #lcsm | |
Janet Freeman-Daily @JFreemanDaily @BrendonStilesMD Looking forward to following #ASCO18 on #SoMe (social media) AND on app--real-time slides and posters for some sessions this year! #LCSM | |
Laura Greco @lgreco_ny @JFreemanDaily Ugh! #lcsm | |
#LCSM Chat @lcsmchat RT @JFreemanDaily: @BrendonStilesMD Looking forward to following #ASCO18 on #SoMe (social media) AND on app--real-time slides and posters for some sessions this year! #LCSM | |
Brendon Stiles @BrendonStilesMD @lcsmchat Just got back from Slovenia! #26ests @thoracic #lcsm | |
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD Big step forward IMHO. Critical to get it right every time. #PatientsFirst #lcsm https://t.co/lyPOUYeTjF | |
Brendon Stiles @BrendonStilesMD RT @JFreemanDaily: @BrendonStilesMD Looking forward to following #ASCO18 on #SoMe (social media) AND on app--real-time slides and posters for some sessions this year! #LCSM | |
Faces of Lung Cancer @LungCancerFaces @tessa_perrin Hey, Tessa! Good to see you. #lcsm | |
Brendon Stiles @BrendonStilesMD RT @TimAllenMDJD: Big step forward IMHO. Critical to get it right every time. #PatientsFirst #lcsm https://t.co/lyPOUYeTjF | |
#LCSM Chat @lcsmchat RT @BrendonStilesMD: @lcsmchat Just got back from Slovenia! #26ests @thoracic #lcsm | |
#LCSM Chat @lcsmchat RT @TimAllenMDJD: Big step forward IMHO. Critical to get it right every time. #PatientsFirst #lcsm https://t.co/lyPOUYeTjF | |
Anita Figueras @scifiknitter @JFreemanDaily @BrendonStilesMD Janet, how does one find info on the real time sessions? #LCSM | |
#LCSM Chat @lcsmchat RT @scifiknitter: @JFreemanDaily @BrendonStilesMD Janet, how does one find info on the real time sessions? #LCSM | |
#LCSM Chat @lcsmchat RT @trnsltnl: | |
Henning Willers, MD @HenningWillers @BrendonStilesMD and trust a negative EBUS ... just to reiterate though, nodal failure rates -it seems to me- are lower than would be expected (absent surgical nodal assessment) - radiation may have effect on microscopic nodal disease. incident dose? abscopal effect? #lcsm | |
Lung Cancer Sux @LungCancerSux RT @JFreemanDaily: @BrendonStilesMD Looking forward to following #ASCO18 on #SoMe (social media) AND on app--real-time slides and posters for some sessions this year! #LCSM | |
Bob Steele @steele_bob Better late than never,,, #lcsm | |
#LCSM Chat @lcsmchat RT @HenningWillers: @BrendonStilesMD and trust a negative EBUS ... just to reiterate though, nodal failure rates -it seems to me- are lower than would be expected (absent surgical nodal assessment) - radiation may have effect on microscopic nodal disease. incident dose? abscopal effect? #lcsm | |
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD 2d through 6th. Wish we overlapped; would be great to visit with you! #lcsm https://t.co/CiIyEAkrnD | |
Yonemoto N @nyonenyone RT @JAMAOnc: Calculations based on FLAURA trial of #osimertinib vs first gen #EGFR TKIs reveals incremental cost-effectiveness ratio for osimertinib exceeds World Health Org threshold for cost-effectiveness as first line Rx in EGFR mut+ NSCLC. Read more https://t.co/Xz8V3vrBkj #LCSM https://t.co/n932Z5QbZU | |
Brendon Stiles @BrendonStilesMD Signing off everyone. Have a great #ASCO18. Soak it all in, but ask the tough questions too! #lcsm | |
Janet Freeman-Daily @JFreemanDaily I'm missing ASCO this year because I have three other trips and presentations in June, and did #AACR18 in April. I too get tired of travel. #LCSM | |
Faces of Lung Cancer @LungCancerFaces @steele_bob Bob! How are you, my friend? #lcsm | |
#LCSM Chat @lcsmchat RT @TimAllenMDJD: 2d through 6th. Wish we overlapped; would be great to visit with you! #lcsm https://t.co/CiIyEAkrnD | |
Bob Steele @steele_bob slowly better, thanks #lcsm | |
Faces of Lung Cancer @LungCancerFaces @BrendonStilesMD So long, Brendon! #LCSM | |
#LCSM Chat @lcsmchat RT @JFreemanDaily: I'm missing ASCO this year because I have three other trips and presentations in June, and did #AACR18 in April. I too get tired of travel. #LCSM | |
Friends of Ernie @ErniesLibrary #adcsm #ancsm #bcsm #blcsm #btsm #crcsm #esophca #gynca #hpbcsm #hncsm #krcc #lcsm #lylsm #melnm #pancsm #pcsm #srcma #stomca #testca #thymca https://t.co/XCjpwarEZL | |
Brendon Stiles @BrendonStilesMD @HenningWillers I concede there probably is some radio-immune effect. I think many problems are result of poor staging or poor selection. #lcsm | |
Anita Figueras @scifiknitter @steele_bob Super glad to hear this, Bob! #LCSM | |
Anita Figueras @scifiknitter @BrendonStilesMD Thanks Brendon! #LCSM | |
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD #LikeABoss #lcsm https://t.co/DuK4qdAuCn | |
#LCSM Chat @lcsmchat RT @BrendonStilesMD: @HenningWillers I concede there probably is some radio-immune effect. I think many problems are result of poor staging or poor selection. #lcsm | |
Janet Freeman-Daily @JFreemanDaily I'm ending this #LCSM chat a bit early tonight--I have a presentation I MUST finish. Sorry for the short notice. Thanks everyone for joining! | |
KC Dill @kasedill Goodnight all I enjoyed the information #lcsm | |
Janet Freeman-Daily @JFreemanDaily @BrendonStilesMD Thanks for participating tonight! Someday I'd love to hear about Slovenia trip. #LCSM | |
#LCSM Chat @lcsmchat RT @JFreemanDaily: I'm ending this #LCSM chat a bit early tonight--I have a presentation I MUST finish. Sorry for the short notice. Thanks everyone for joining! | |
#LCSM Chat @lcsmchat RT @trnsltnl: | |
Janet Freeman-Daily @JFreemanDaily @scifiknitter @BrendonStilesMD I registered for the conference so I could access the content. #LCSM | |
Anita Figueras @scifiknitter @JFreemanDaily Thanks, Janet! #LCSM | |
Faces of Lung Cancer @LungCancerFaces 'Night everyone! Thanks for moderating tonight @JFreemanDaily #lcsm | |
Anita Figueras @scifiknitter @JFreemanDaily @BrendonStilesMD Attending from the comfort of your home, with informed commentary from your cat - there are worse ways to attend a conference. #LCSM | |
Friends of Ernie @ErniesLibrary #adcsm #ancsm #bcsm #blcsm #btsm #crcsm #esophca #gynca #hpbcsm #hncsm #krcc #lcsm #lylsm #melnm #pancsm #pcsm #srcma #stomca #testca #thymca https://t.co/XCjpwarEZL https://t.co/Sd2pBRVuZ2 |
#LCSM content from Twitter.